SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-073469
Filing Date
2014-02-27
Accepted
2014-02-27 17:30:07
Documents
7
Period of Report
2014-02-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d684258d8k.htm 8-K 24623
2 EX-1.1 d684258dex11.htm EX-1.1 195710
3 EX-4.1 d684258dex41.htm EX-4.1 69778
4 EX-4.2 d684258dex42.htm EX-4.2 69834
5 EX-4.3 d684258dex43.htm EX-4.3 57613
6 EX-5.1 d684258dex51.htm EX-5.1 10070
7 GRAPHIC g684258g55u11.jpg GRAPHIC 2323
  Complete submission text file 0001193125-14-073469.txt   432253
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 14650385
SIC: 2834 Pharmaceutical Preparations